Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.
Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.